Owkin

Estonia and French AI biotech company Owkin have announced a partnership focused on sovereign AI in biology, aimed at developing AI capabilities for biological and medical research that remain under national control. The agreement signals Estonia's push to build independent AI infrastructure in the life sciences, though further details on funding and scope have not yet been made public.